Mauro Gitto on Comparison of Paclitaxel-coated Balloons with Urea or Iopromide
Mauro Gitto, Interventional Cardiologist at Humanitas Research Hospital, shared on LinkedIn:
”Our latest article comparing two contemporary paclitaxel-coated balloons (urea-coated Prevail vs iopromide-coated Sequent Please) for the treatment of both de novo and ISR lesions.
As evidence in support of DCB-based PCI grows, more and more device-comparing studies are needed!
Full text here.”
Read the full article here.
Article: Paclitaxel-coated balloon with urea or iopromide as the excipient for treatment of coronary artery disease
Authors: Mauro Gitto, Francesco Tartaglia, Pier Pasquale Leone, Gianmaria Calamita, Alessandro Gabrielli, Leon Gramss, Marco Luciano Rossi, Damiano Regazzoli, Gabriele Gasparini, Ottavia Cozzi, Bernhard Reimers, Giulio Giuseppe Stefanini, Antonio Mangieri, Azeem Latib, Antonio Colombo
Stay updated on all scientific advances with Hemostasis Today.
-
May 15, 2026, 10:48Ahmed Elshahat: Thrilled to Share Our Latest Paper on Opioid Overdose and Cardiovascular Mortality
-
May 15, 2026, 10:47Fouad Al-Noor: Congratulations to NBCA on This Landmark VTE Prevention Victory
-
May 15, 2026, 10:41Faisal Almutairi: Blood Components Overview
-
May 15, 2026, 10:29Connie Montgomery: Every Patient Deserves Representation in Clinical Research
-
May 15, 2026, 10:28Arjun Law: Transplant Should Always Be a Consideration for Severe AA Irrespective of Donor
-
May 15, 2026, 09:45Finding the Right Balance in Hemophilia Treatment – Global Hemophilia Report
-
May 15, 2026, 09:28Abel Hailu: A New Chapter for Pediatric Oncology and Hematology Care in Ethiopia
-
May 15, 2026, 09:26Abdul Mannan: Does Pregnancy Cause Aplastic Anaemia?
-
May 15, 2026, 09:20Join the Global Conversation on Health Equity in Bleeding Disorders – WFH